Institution statistics

UNIVERSITAETSKLINIKUM WUERZBURG - KLINIKUM DER BAYERISCHEN JULIUS-MAXIMILIANS-UNIVERSITAT - DE 

Ranking results:

Past rankings:
2019
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
2018
Criterium:Position:
Overall Score:800-900
Total Project Funding per Partner:600-700
Total Number of Projects:> 1000
Networking Rank (Reputation):600-700
Ranking timeline:

European project participation (2010-01-01 - 2021-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 19
As coordinator: 3
As participant: 15
Sole participant: 1
Coordinator / Participant Ratio: 0.2*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2021 8.728.185 13.873.543 2.355.283 1 2
2020 150.000 22.280.038 1.590.125 1 3
2019 0 22.532.675 1.571.001 3
2018 6.097.875 6.752.251 2.768.899 1 2
2017 0 46.408.654 2.455.986 5
2015 5.564.395 0 1.714.513 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
NOVARTIS PHARMA4
ACADEMISCH ZIEKENHUIS GRONINGEN3
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG3
BUNDESINSTITUT FUR IMPFSTOFFE UND BIOMEDIZINISCHE ARZNEIMITTEL3
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V3
JANSSEN PHARMACEUTICA NV3
KATHOLIEKE UNIVERSITEIT LEUVEN3
MEDIZINISCHE UNIVERSITAET WIEN3
NOVO NORDISK3
PFIZER LIMITED3
TCURX3
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD3
UNIVERSIDAD DE NAVARRA3
UNIVERSITAETSMEDIZIN DER JOHANNES GUTENBERG UNIVERSITAET MAINZ3
UNIVERSITY OF BIRMINGHAM3
ARTTIC2
BAYER2
BIOSCI CONSULTING BVBA2
ELI LILLY AND COMPANY LIMITED2
F HOFFMANNLA ROCHE2
FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON INSTITUT DE RECERCA2
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE2
INFORMATION TECHNOLOGY FOR TRANSLATIONAL MEDICINE2
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE2
KING'S COLLEGE LONDON2
KLINIKUM DER UNIVERSITAET REGENSBURG2
LEIDS UNIVERSITAIR MEDISCH CENTRUM2
MEDIZINISCHE UNIVERSITAT INNSBRUCK2
MERCK SHARP & DOHME CORP2
OREBRO UNIVERSITY2
OSPEDALE PEDIATRICO BAMBINO GESU2
OTTOVONGUERICKEUNIVERSITAET MAGDEBURG2
PHILIPPS UNIVERSITAET MARBURG2
SANOFIAVENTIS2
SEMMELWEIS EGYETEM2
SERVICIO ANDALUZ DE SALUD2
STICHTING KATHOLIEKE UNIVERSITEIT2
STICHTING VUMC2
UNIVERSITAETSKLINIKUM JENA2
UNIVERSITAIR MEDISCH CENTRUM UTRECHT2
UNIVERSITY COLLEGE LONDON2
UNIVERSITY OF BRISTOL2
UNIVERSITY OF NEWCASTLE UPON TYNE2
ABBVIE INC1
ACADEMIC MEDICAL CENTRE AMSTERDAM1
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM1
ACADEMISCH ZIEKENHUIS LEIDEN1
ADD INFORMATION SERVICES1
AE MEDICALIS BV1
AGLARIS CELL SL1
ALACRIS THERANOSTICS1
ALBERT LUDWIGS UNIVERSITAET FREIBURG1
ALLERGAN LIMITED1
ANTAROS MEDICAL AB1
ARTEEVO TECHNOLOGIES1
ARTEMIS BIOSUPPORT BV1
ASOCIACION CENTRO DE INVESTIGACION COOPERATIVA EN BIOCIENCIAS1
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS1
ASSOCIACAO PARA INVESTIGACAO E DESENVOLVIMENTO DA FACULDADE DE MEDICINA1
ASTELLAS PHARMA EUROPE BV1
ASTRAZENECA1
ASTRAZENECA AB1
AUSTRIAN RESEARCH CENTERS SIEBERDORF1
AZIENDA OSPEDALIERA DI PERUGIA1
BAYERISCHE JULIUS MAXIMILIANS UNIVERSITAET WUERZBURG1
BCOM1
BIONORICA RESEARCH1
BLUEBIRD BIO INC1
BOSTON SCIENTIFIC LIMITED1
BRISTOLMYERS SQUIBB COMPANY CORP1
CELGENE MANAGEMENT SARL1
CELLIX LIMITED1
CELLULAR THERAPEUTICS LIMITED1
CENTRE HOSPITALIER REGIONAL ET UNIVERSITAIRE DE LILLE1
CHARITE UNIVERSITAETSMEDIZIN BERLIN1
CONCENTRIS RESEARCH MANAGEMENT1
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS1
CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER1
CONSORCIO CENTRO DE INVESTIGACION BIOMEDICA EN RED MP1
COVANCE LABORATORIES1
DIMOKRITIO PANEPISTIMIO THRAKIS1
DRKBLUTSPENDEDIENST BADENWURTTEMBERGHESSEN GGMBH1
DYNAMIC421
EBERHARD KARLS UNIVERSITAET TUEBINGEN1
EBERS MEDICAL TECHNOLOGY SL1
ECHOSENS1
EIBIR GEMEINNUETZIGE GMBH ZUR FOERDERUNG DER ERFORSCHUNG DER BIOMEDIZINISCHEN BILDGEBUNG1
EKON MODELING SOFWARE SYSTEMS LTDEKON1
ELLEGAARD GOTTINGEN MINIPIGS AS1
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM1
ERASMUS UNIVERSITEIT ROTTERDAM1
ETHNIKO KAI KAPODISTRIAKO PANEPISTIMIO ATHINON1
ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS1
EUROPEAN ASSOCIATION FOR THE STUDYOF THE LIVER1
EUROPEAN CANCER PATIENT COALITION1
EUROPEAN FORUM FOR GOOD CLINICAL PRACTICE1
EUROPEAN HEMATOLOGY ASSOCIATION1
EUROPEAN MOLECULAR BIOLOGY LABORATORY1
EXALENZ BIOSCIENCE1
FACULDADE DE FARMACIA DA UNIVERSIDADE DE LISBOA1
Constancy:

Total number of partners:321

Partner loyalty:
Frequent Partner: (> 2 projects): 46
Rare Partner: 275

Frequent / Rare Partner Ratio: 0.17

Diversity:

Subjects:
Subject:No:
Diversity index:0
Categories:
Category:No:

Project overview:

Start dateProjectacronymrolefundingpartners
2021-01-01Artificial Intelligence-driven, Decentralized Production for Advanced Therapies in the Hospital AIDPATHparticipant9.860.99212
2021-01-01Accelerating Development and Improving Access to CAR and TCR-engineered T cell therapy T2EVOLVEcoordinator8.728.18527
2021-01-01Serotonin and BEYOND: Brain development research Excelling Young Ones in Neurotechnologies and Discoveries SEROTONIN and BEYONDparticipant4.012.55111
2020-03-01Disposable well-plate inserts and perfusion chambers for easy-to-use and generic microchannel creation in 3D tissue culture Design2Flowcoordinator150.0001
2020-01-01Computational biomechanics and bioengineering 3D printing to develop a personalized regenerative biological ventricular assist device to provide lasting functional support to damaged hearts BRAV3participant8.000.00014
2020-01-01Unification of treatments and Interventions for Tinnitus patients UNITIparticipant5.989.34413
2020-01-01PharmaLedger PharmaLedgerparticipant8.290.69429
2019-12-01Immune Safety Avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapies imSAVARparticipant10.999.31628
2019-01-01Immune DIREcted and Cancer-selective immunoTherapy I-DireCTparticipant2.533.3585
2019-01-01Investigating Mechanisms and Models Predictive of Accessibility of Therapeutics (IM2PACT) Into The Brain IM2PACTparticipant9.000.00027
2018-08-01Targeting neuroinflammation to combat pathological pain in neurodegenerative diseases and chronic pain syndromes TOBeATPAINparticipant2.870.3598
2018-01-01TArgeting Platelet Adhesion receptors in thrombosiS TAPASparticipant3.881.89213
2018-01-01SLAMF7-CAR T cells prepared by Sleeping Beauty gene-transfer for immunotherapy of multiple myeloma – a rare hematologic disease CARAMBAcoordinator6.097.87510
2017-12-01PREvention of STroke in Intracerebral haemorrhaGE survivors with Atrial Fibrillation PRESTIGE-AFparticipant6.958.89612
2017-11-01Liver Investigation: Testing Marker Utility in Steatohepatitis LITMUSparticipant15.797.88156
2017-09-01Effects of Nutrition and Lifestyle on Impulsive, Compulsive, and Externalizing behaviours Eat2beNICEparticipant11.144.56218
2017-06-01Implications of Medical Low Dose Radiation Exposure MEDIRADparticipant9.995.14635
2017-01-01European Network on Anti-Cancer Immuno-Therapy Improvement by modification of CAR and TCR Interactions and Nanoscale Geometry EN_ACTI2NGparticipant2.512.16913
2015-11-01Application of combined gene and cell therapy within an implantable therapeutic device for the treatment of severe hemophilia A HemAcurecoordinator5.564.3958
Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum